Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Life Sciences Limited
02 1Dipharma Francis S. r. l.
03 1Glenmark Life Sciences Limited
04 3Hetero Labs Limited
05 1Kotobuki Pharmaceutical Co., Ltd.
06 2Yamamoto Chemical Industry Co., Ltd.
01 2Japanese Pharmacopoeia Zonisamide
02 6Zonisamide
03 1Zonisamide [D]
01 5India
02 1Italy
03 3Japan
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Japanese Pharmacopoeia Zonisamide
Registration Number : 231MF10074
Registrant's Address : 215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala MIDC, Chakala, An...
Initial Date of Registration : 2019-03-19
Latest Date of Registration : 2021-03-15
Registration Number : 229MF10153
Registrant's Address : Via Bissone, 5, 20021-Baranzate, Milano, Italy
Initial Date of Registration : 2017-08-04
Latest Date of Registration : 2017-08-04
Registration Number : 305MF10014
Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Mahara...
Initial Date of Registration : 2023-02-02
Latest Date of Registration : 2023-02-02
Registration Number : 305MF10011
Registrant's Address : 7-2-A2,Hetero Corporate,Industrial Estates Sanath Nagar,Hyderabad-500 018 Telangana I...
Initial Date of Registration : 2023-01-25
Latest Date of Registration : 2023-01-25
Registration Number : 305MF10021
Registrant's Address : 7-2-A2,Hetero Corporate,Industrial Estates Sanath Nagar,Hyderabad-500 018 Telangana I...
Initial Date of Registration : 2023-02-08
Latest Date of Registration : 2023-10-25
Registration Number : 230MF10115
Registrant's Address : 7-2-A2,Hetero Corporate,Industrial Estates Sanath Nagar,Hyderabad-500 018 Telangana I...
Initial Date of Registration : 2018-08-22
Latest Date of Registration : 2018-08-22
Registration Number : 303MF10061
Registrant's Address : Nagano Prefecture Hanishina District Sakaki Town Sakaki Oaza 6351
Initial Date of Registration : 2021-04-08
Latest Date of Registration : 2021-04-08
Japanese Pharmacopoeia Zonisamide
Registration Number : 230MF10086
Registrant's Address : 1-4 Funatsucho, Wakayama City, Wakayama Prefecture
Initial Date of Registration : 2018-07-20
Latest Date of Registration : 2021-10-07
Registration Number : 217MF10565
Registrant's Address : 1-4 Funatsucho, Wakayama City, Wakayama Prefecture
Initial Date of Registration : 2005-09-09
Latest Date of Registration : 2019-01-29
A Zonisamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zonisamide, including repackagers and relabelers. The FDA regulates Zonisamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zonisamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zonisamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zonisamide supplier is an individual or a company that provides Zonisamide active pharmaceutical ingredient (API) or Zonisamide finished formulations upon request. The Zonisamide suppliers may include Zonisamide API manufacturers, exporters, distributors and traders.
click here to find a list of Zonisamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Zonisamide Drug Master File in Japan (Zonisamide JDMF) empowers Zonisamide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Zonisamide JDMF during the approval evaluation for pharmaceutical products. At the time of Zonisamide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Zonisamide suppliers with JDMF on PharmaCompass.
We have 6 companies offering Zonisamide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
